Role of circular RNA in neurological disease

Role of circular RNA in neurological disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detalles Bibliográficos
Autor principal:	Salsabil, Labiba
Otros Autores:	Chowdhury, Namara Mariam
Formato:	Tesis
Lenguaje:	English
Publicado:	Brac University 2024
Materias:	Circular RNA circRNA Neurological disorder Alzheimer’s disease Parkinson’s disease Nervous system > Diseases. Molecular neurobiology.
Acceso en línea:	http://hdl.handle.net/10361/23932

Ejemplares similares

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
por: Dey, Manashi
Publicado: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
por: Halim, Rabea
Publicado: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
por: Zaman, Rubaiyat
Publicado: (2024)

Targeting circular RNA for cardiovascular diseases
por: Sarkar, Deepannita
Publicado: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
por: Bakar, Osama Bin Abu
Publicado: (2024)

RNA drugs and RNA targets for small molecules: Prospects and challenges
por: Islam, Md. Raihanul
Publicado: (2024)

Implications of unusual non-coding RNAs in human diseases
por: Ahmed, Tazkia
Publicado: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
por: Mostofa, Golam
Publicado: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
por: Chowdhury, Sariya Uzrat
Publicado: (2022)

A review on optogenetics and its potential in neurological disorder management
por: Armin, Fariza
Publicado: (2024)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
por: Suraiya, Tasnia Iffat
Publicado: (2023)

Gene editing for neurodegenerative diseases-A review
por: Sharna, Anika Islam
Publicado: (2023)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
por: Ferdous, Labiba
Publicado: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
por: Alim, Abdul
Publicado: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
por: Annee, Israt Jahan
Publicado: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
por: Tasneem, Sadia
Publicado: (2021)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
por: Nawar, Numia
Publicado: (2021)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
por: Tabassum, Nadira
Publicado: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
por: Afsana, Nourin
Publicado: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
por: Islam, Md. Irfath
Publicado: (2023)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
por: Ahmad, Rafid Uddin, et al.
Publicado: (2024)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
por: Mithila, Sabekun Nahar
Publicado: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
por: Shehab, Habibul Mohsin
Publicado: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
por: Mahaleka, Aarshi
Publicado: (2024)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
por: Aziz, Farhin
Publicado: (2019)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
por: Islam, Md. Rakibul
Publicado: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
por: Karmaker, Swastika
Publicado: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
por: Key, Nasrin Sultana
Publicado: (2023)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
por: Rawshan, A. E. Maisha
Publicado: (2022)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
por: Ishrat, Nowshin
Publicado: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
por: Saha, Bithi Rani
Publicado: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
por: Chowdhury, Amal
Publicado: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
por: Afreen, Nuraia
Publicado: (2021)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
por: Hassan, Md. Muhtaz
Publicado: (2020)

A review on the role of Myc and miRNA in Glioblastoma multiforme
por: Naureen, Ishrat
Publicado: (2022)

Review on: the mechanism and function of Glia in parkinson's disease
por: Abedin, Khondokar Mezbahul
Publicado: (2023)

Alzheimer's disease and marriage : an intimate account /
por: Wright, Lore K.
Publicado: (1993)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
por: Tamanna, Mst. Taskia
Publicado: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
por: Nuha, Nabiha Tahsin
Publicado: (2024)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
por: Asaduzzaman, et al.
Publicado: (2021)